characteristics.text: SAMN41656131
characteristics.characteristic: External Id
characteristics.text: Immuno-Oncology, Obstetrics&Gynecology, University Medical Center Groningen
characteristics.characteristic: INSDC center name
characteristics.text: 2024-07-19T00:50:17.343Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-07-19T00:50:17.343Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS21499367
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS21499367
characteristics.characteristic: SRA accession
characteristics.text: CD8 T cell
characteristics.characteristic: cell type
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: MMRd tumor, WT T cells
characteristics.characteristic: genotype
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Endometrial tumor tissue
characteristics.characteristic: source_name
characteristics.text: Endometrial tumor tissue
characteristics.characteristic: tissue
characteristics.text: PAM010, CD8 T cells, scTCRseq
characteristics.characteristic: title
characteristics.text: Pembrolizumab 200mg Q3W; 2 cycles
characteristics.characteristic: treatment